α1 and α2-adrenergic agonists on cirrhotic patients with refractory ascites
Author:
Affiliation:
1. Liver Unit; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institute of Research; Universitat Autònoma de Barcelona; Barcelona Spain
2. CIBEREHD; Instituto de Salud Carlos III; Madrid Spain
Funder
Instituto de Salud Carlos III
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12941/fullpdf
Reference20 articles.
1. Compensated cirrhosis: natural history and prognostic factors;Gines;Hepatology,1987
2. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites;Angeli;Hepatology,1998
3. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis;Runyon;Hepatology,2013
4. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis;European Association for the Study of the Liver;J Hepatol,2010
5. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis;Gines;Gastroenterology,1988
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A randomized dose-escalation study on the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of a novel recombinant human albumin in healthy subjects;European Journal of Pharmaceutical Sciences;2021-10
2. Involvement of G proteins and Rho kinase in α1-adrenoceptor mediated contractions of the rat portal vein;Canadian Journal of Physiology and Pharmacology;2021-06
3. Impairment of natriuresis and diuresis induced by intrarenal adrenoceptor mechanisms in an experimental model of cirrhosis in rats;Heliyon;2019-12
4. Current and future pharmacological therapies for managing cirrhosis and its complications;World Journal of Gastroenterology;2019-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3